End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,370 KRW | +0.35% | +7.16% | -15.27% |
Business Summary
Number of employees: 457
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunodiagnostic Cartrige
83.3
%
| 97,150 | 82.3 % | 111,814 | 83.3 % | +15.09% |
Immunodiagnostic Device
13.3
%
| 13,469 | 11.4 % | 17,900 | 13.3 % | +32.90% |
Other
2.6
%
| 7,111 | 6.0 % | 3,462 | 2.6 % | -51.31% |
Hemoglobin Diagnostic Device
0.8
%
| 347 | 0.3 % | 1,043 | 0.8 % | +200.66% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
20.1
%
| 22,230 | 18.8 % | 27,021 | 20.1 % | +21.55% |
Middle East and North Africa
18.6
%
| 19,070 | 16.2 % | 24,944 | 18.6 % | +30.80% |
Asia
18.1
%
| 21,175 | 17.9 % | 24,336 | 18.1 % | +14.93% |
America
13.9
%
| 19,480 | 16.5 % | 18,613 | 13.9 % | -4.45% |
China
13.4
%
| 20,064 | 17.0 % | 18,004 | 13.4 % | -10.27% |
Africa
8.8
%
| 9,831 | 8.3 % | 11,820 | 8.8 % | +20.24% |
South Korea
7.1
%
| 6,226 | 5.3 % | 9,481 | 7.1 % | +52.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 97-12-31 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 08-12-31 |
Yong-Hwan Byeon
BRD | Director/Board Member | 69 | 15-07-27 |
Kang-Oh Kim
BRD | Director/Board Member | 51 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ui-Yeol Choe
CEO | Chief Executive Officer | 63 | 97-12-31 |
Kang-Oh Kim
BRD | Director/Board Member | 51 | 16-12-31 |
Ki-Bong Nam
CTO | Chief Tech/Sci/R&D Officer | 68 | 08-12-31 |
In-Bum Seo
BRD | Director/Board Member | 58 | 15-07-27 |
Yong-Hwan Byeon
BRD | Director/Board Member | 69 | 15-07-27 |
Sang-Kyu Park
BRD | Director/Board Member | 71 | 18-03-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,486,560 | 13,880,020 ( 59.10 %) | 1,517,764 ( 6.462 %) | 59.10 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BODITECH MED INC. 6.43% | 1,511,094 | 6.43% | 17,383,973 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.27% | 282M | |
-41.90% | 2.95B | |
+19.36% | 1.88B | |
-1.05% | 1.63B | |
+33.96% | 1.34B | |
-16.83% | 959M | |
-21.96% | 888M | |
+7.07% | 842M | |
-26.98% | 623M | |
+10.85% | 513M |
- Stock Market
- Equities
- A206640 Stock
- Company Boditech Med Inc.